Form 8-K - Current report:
SEC Accession No. 0001558370-22-016731
Filing Date
2022-11-08
Accepted
2022-11-08 07:03:37
Documents
14
Period of Report
2022-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vygr-20221108x8k.htm   iXBRL 8-K 40877
2 EX-99.1 vygr-20221108xex99d1.htm EX-99.1 110401
3 GRAPHIC vygr-20221108xex99d1001.jpg GRAPHIC 9417
  Complete submission text file 0001558370-22-016731.txt   294410

Data Files

Seq Description Document Type Size
4 EX-101.SCH vygr-20221108.xsd EX-101.SCH 3167
5 EX-101.LAB vygr-20221108_lab.xml EX-101.LAB 15268
6 EX-101.PRE vygr-20221108_pre.xml EX-101.PRE 9843
8 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20221108x8k_htm.xml XML 4663
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 221367173
SIC: 2836 Biological Products, (No Diagnostic Substances)